These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 14018346)

  • 21. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY].
    NITTI V
    Chemotherapia (Basel); 1963; 12():482-91. PubMed ID: 14185774
    [No Abstract]   [Full Text] [Related]  

  • 22. [The present position of rifamycin SV in the therapy of tuberculous processes].
    RESCIGNO B
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():238-43. PubMed ID: 13981724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences on the antitubercular activity of rifamycin SV used by local route].
    ZORZOLI P; MONCALVO F; MOREO GC
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():321-3. PubMed ID: 14003950
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy with rifamycin SV in some manifestations of extrapulmonary tuberculosis].
    SARDI A; COLOMBI M; VILLANI E
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():330-3. PubMed ID: 13991476
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rifamycin SV in female genital tuberculosis].
    REVELLI E
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():324-5. PubMed ID: 13981846
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy with rifamycin SV in some manifestations of tuberculosis of the urinary tract].
    COLOMBI M; SARDI A
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():326-9. PubMed ID: 14022425
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the antimycobacterial activity of rifamycin SV. Experimental research "in vitro" and "in vivo" and administration by local route in clinical practice].
    ZORZOLI P; MONCALVO F; MOREO GC
    G Ital Tuberc Mal Torace; 1962; 16():226-34. PubMed ID: 14003951
    [No Abstract]   [Full Text] [Related]  

  • 28. [Some observations on the mechanism of action of Rifamycin SV].
    TSUKAMURA M; IMAZU S; TSUKAMURA S; MIZUNO S
    Ann Ist Carlo Forlanini; 1963; 23():40-50. PubMed ID: 13994574
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rifomycin SV in intracavitary aspiration].
    VACCARO L; SISTI F
    G Mal Infett Parassit; 1962 Sep; 14():511-7. PubMed ID: 13995642
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE USE OF RIFAMYCIN SV IN TUBERCULOSIS. PRACTICAL GUIDELINES].
    MONALDI V
    Chemotherapia (Basel); 1963; 12():569-76. PubMed ID: 14185792
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening of rifamycin producing marine sponge bacteria by LC-MS-MS.
    Hewavitharana AK; Shaw PN; Kim TK; Fuerst JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):362-6. PubMed ID: 17301003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rifamycin SV in the treatment of pyogenic dermatoses].
    ZELCER I
    Dia Med; 1963 Jan; 35():68-9. PubMed ID: 14003403
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical studies on a new antibiotic, rifamycin SV].
    CHO NK; SUNADA Y; NOHARA S
    Showa Igakkai Zasshi; 1963 May; 23():86-7. PubMed ID: 14020941
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute lung diseases in children. Their treatment with rifamycin SV].
    USOZ O; CALLEGARI E; BERRIA MI
    Sem Med; 1963 Apr; 122():659-62. PubMed ID: 13995548
    [No Abstract]   [Full Text] [Related]  

  • 35. [Susceptibility of mycobacteria to a new antibiotic, rifamycin SV].
    TSUKAMURA S; TSUKAMURA M
    Kekkaku; 1962 Oct; 37():586-90. PubMed ID: 13994585
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical effects of Rifamycin SV on bacterial infections of the respiratory organs].
    TSUKAMURA M; TAKENAKA T; KURITA I; TSUKAMURA
    Kekkaku; 1963 Feb; 38():57-62. PubMed ID: 13994576
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental studies on the physicochemical nature and on the practical importance of the bonds between rifamycin SV, polyvinylpyrrolidone and proteins].
    CURCI G; NINNI A
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():190-209. PubMed ID: 14024289
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures.
    El-Enshasy HA; Beshay UI; El-Diwany AI; Omar HM; El-Kholy AG; El-Najar R
    Acta Microbiol Pol; 2003; 52(3):301-13. PubMed ID: 14743983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?
    Wallis RS
    Am J Respir Crit Care Med; 2005 Jul; 172(1):4-5. PubMed ID: 15980108
    [No Abstract]   [Full Text] [Related]  

  • 40. Divalent metal ion catalysis of the oxidation of rifamycin SV to rifamycin S.
    Scrutton MC
    FEBS Lett; 1977 Jun; 78(2):216-20. PubMed ID: 885245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.